Literature DB >> 21726616

Development of mini-tablets with 1mm and 2mm diameter.

Corinna Tissen1, Katharina Woertz, Joerg Breitkreutz, Peter Kleinebudde.   

Abstract

The feasibility of formulating mini-tablets with 1mm diameter on a rotary-die press in comparison to mini-tablets of 2mm was investigated. To gain insight into the production of 1mm mini-tablets, three model drugs of different compression characteristics were chosen, namely quinine hydrochloride, ibuprofen and spray-dried gentian extract. A high drug load in combination with robust and reproducible mechanical properties was requested. Depending on the individual drug substance, mini-tablets were produced by direct compression or after roll-compaction/dry granulation. The tensile strength, mass, and their variation coefficients were determined to assess the mechanical properties of the tablets. The content uniformity and the dissolution behavior of selected batches were analyzed. For the first time 1mm mini-tablets could be successfully produced by direct compression (90% quinine hydrochloride; 90% dried gentian extract) and after roll compaction (70% ibuprofen). Depending on the applied compression pressure, 1mm mini-tablets with quinine hydrochloride exhibited robust mechanical properties (e.g. median tensile strength of 2.02N/mm(2)) with equal or lower variance of distribution compared to the 2mm compacts. With respect to content uniformity of dosage forms, 1mm mini-tablets containing 80% quinine hydrochloride met the requirements of the European Pharmacopeia (AV=6.8).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726616     DOI: 10.1016/j.ijpharm.2011.06.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Retention of polyphenolic species in spray-dried blackberry extract using mannitol as a thermoprotectant.

Authors:  Joshua A Eldridge; Debra Repko; Russell J Mumper
Journal:  J Med Food       Date:  2014-06-03       Impact factor: 2.786

2.  Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.

Authors:  Monika Lavan; Xueqi Wang; Robyn McCain; Amber Jannasch; Bruce Cooper; Scott Hostetler; Stephen Byrn; Gregory Knipp
Journal:  AAPS PharmSciTech       Date:  2021-01-08       Impact factor: 3.246

3.  Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling.

Authors:  Michele Georges Issa; Natalia Vieira de Souza; Bruna Wenyi Chuang Jou; Marcelo Dutra Duque; Humberto Gomes Ferraz
Journal:  Pharmaceutics       Date:  2022-04-19       Impact factor: 6.525

4.  Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.

Authors:  H Lou; M Liu; L Wang; S R Mishra; W Qu; J Johnson; E Brunson; H Almoazen
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

Review 5.  Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

Authors:  Fang Liu; Sejal Ranmal; Hannah K Batchelor; Mine Orlu-Gul; Terry B Ernest; Iwan W Thomas; Talia Flanagan; Catherine Tuleu
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 6.  Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.

Authors:  Felipe L Lopez; Terry B Ernest; Catherine Tuleu; Mine Orlu Gul
Journal:  Expert Opin Drug Deliv       Date:  2015-07-13       Impact factor: 6.648

7.  Bioadhesive mini-tablets for vaginal drug delivery.

Authors:  Marianne Hiorth; Susanne Nilsen; Ingunn Tho
Journal:  Pharmaceutics       Date:  2014-08-27       Impact factor: 6.321

8.  Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults.

Authors:  C Guittet; C Roussel-Maupetit; M A Manso-Silván; F Guillaumin; F Vandenhende; L A Granier
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

9.  Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa.

Authors:  Valentinë Elezaj; Ard Lura; Luis Canha; Jörg Breitkreutz
Journal:  Pharmaceutics       Date:  2022-03-05       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.